Trials / Recruiting
RecruitingNCT05606809
Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,500 (estimated)
- Sponsor
- AfterROSC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Calculation of early prognosis score | Early prognosis score will be calculated at intensive care unit admission for each patient based on clinical and biological values as required |
Timeline
- Start date
- 2022-11-02
- Primary completion
- 2027-09-30
- Completion
- 2027-12-31
- First posted
- 2022-11-07
- Last updated
- 2025-10-03
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05606809. Inclusion in this directory is not an endorsement.